Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
Cytokeratin 19 Double Nickase Plasmid (h): sc-400281-NIC
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- Cytokeratin 19 Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- Cytokeratin 19 Double Nickase Plasmid (h) and Cytokeratin 19 Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting KRT19. One or both designs may be available
- Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: Cytokeratin 19 Antibody (A-3): sc-376126
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Cytokeratin 19 Double Nickase Plasmid (h) | sc-400281-NIC | 20 µg | $410.00 | |||
Cytokeratin 19 Double Nickase Plasmid (h2) | sc-400281-NIC-2 | 20 µg | $410.00 |
KRT19 encodes cytokeratin 19, a type I intermediate filament protein that contributes to epithelial cytoskeletal organization, cellular mechanical stability, and maintenance of polarity. Cytokeratin 19 participates in keratin filament assembly and remodeling processes that coordinate with cell adhesion and junctional complexes, influencing epithelial differentiation and stress responses. Altered KRT19 expression is frequently used as a molecular indicator of epithelial lineage and cellular state changes observed during dysplasia, invasion-associated phenotypic switching, and metastatic dissemination. In human disease research, KRT19 is commonly examined in the context of tumor heterogeneity, epithelial marker regulation, and signaling programs linked to migration and survival.
Cytokeratin 19 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the KRT19 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within KRT19. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt KRT19 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of KRT19-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.